Patients See First Savings From Biden’s Drug Price Push, as Pharma Lines Up Its Lawyers - KFF Health News
Source: KHN
Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst, one of the pricey medications that treat his multiple myeloma, a blood cancer he was diagnosed with in 2010. The drugs have kept his cancer at bay. But their rapidly increasing costs so infuriated Mitchell that he was inspired to create an advocacy movement. Patients for Affordable Drugs, which he founded in 2016, was instrumental in…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at KHN